Ignite Creation Date:
2025-12-25 @ 2:00 AM
Ignite Modification Date:
2025-12-26 @ 2:17 AM
Study NCT ID:
NCT05226494
Status:
RECRUITING
Last Update Posted:
2025-06-04
First Post:
2021-12-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Tolerability of Fb-PMT in Recurrent Glioblastoma
Sponsor:
NanoPharmaceuticals LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-23
Start Date Type:
ACTUAL
Primary Completion Date:
2026-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-10
Completion Date Type:
ESTIMATED
First Submit Date:
2021-12-03
First Submit QC Date:
None
Study First Post Date:
2022-02-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-29
Last Update Post Date:
2025-06-04
Last Update Post Date Type:
ACTUAL